A demo

889 Articles Matching "prices"

Express Scripts offers new formulary for lower list-price drugs

Nov 14, 2018 , Reuters
Express Scripts Holding Co on Tuesday announced a new drug reimbursement list with lower U.S. prices for brand-name medications, as a way to encourage drugmakers to move away from paying rebates after a prescription is filled. The manager of prescription drug benefits for large corporate employers and government health plans said its new National Preferred Flex Formulary will be available as of Jan. 1 to all clients....
Read more

Expert: Pressure To Lower Drug Prices May Lead To Recalls, Particularly Of Generics

Nov 09, 2018 , NewsLine - Healthcare Professionals
The pressure being placed on drug companies to reduce prices as a result of President Donald Trump’s recent proposals, likely will intensify with the Democrats’ taking control of the House of Representatives in the mid-term elections. Research by George Ball, assistant professor of operations and d......
Read more

Coherus prices biosimilar to Amgen's Neulasta at 33 percent discount

Nov 09, 2018 , Reuters
Coherus BioSciences Inc said on Thursday it would price its biosimilar to Amgen Inc's infection-fighting treatment, Neulasta, at a 33 percent discount....
Read more

Medicaid, Drug Prices Could See Big Election Impacts

Nov 09, 2018 , Healthcare Business News
Nov. 7—On Tuesday, voters in three states approved expanding Medicaid eligibility to a total of more than 300,000 people....
Read more

House Dems In New Seats Of Power Will Steer Health Policy, Attack Drug Prices

Nov 08, 2018 , Kaiser Health News
Democrats, who have a history of championing the Affordable Care Act and railing about drug prices, will now chair several house...
Read more
Demo

Encouraging patients to shop around amidst high healthcare prices

Nov 03, 2018 , Modern Healthcare Breaking News
By offering incentives to patients, Vitals saves both them and their employers and health plans...
Read more

Trump Plans to Lower Medicare Part D Prices, Not Just Part B

Nov 02, 2018 , RxList
The Trump administration is preparing to unveil a proposal for lower prices for the Medicare Part D pharmacy benefit. This would follow last week's release of an outline for a test of a new Medicare Part B approach to paying for drugs administered by...
Read more

Trump Plans to Lower Medicare Part D Prices

Nov 02, 2018 , eMedicine Health
Trump Plans to Lower Medicare Part D Prices, Not Just Part...
Read more

Editorial: Drug price controls? A good idea, but don't bet on it

Nov 02, 2018 , Modern Healthcare Breaking News
Once the heat of the campaign dissipates, a majority in both parties will remain susceptible to their main argument that high prices are necessary to promote...
Read more

HHS drug pricing czar Dan Best dies

Nov 02, 2018 , Modern Healthcare Breaking News
The former CVS Caremark executive was brought into HHS to lead the drive to lower drug...
Read more

Health Insurance Prices: Trick Or Treat For Midterm Voters?

Nov 01, 2018 , Forbes
Contrary to claims from politicians and news pundits, the latest news on insurance exchange prices (a) doesn’t signal market stabilization, (b) doesn’t reflect broader healthcare trends and (c) isn’t the result of improved medical...
Read more
Cardon Children's Medical Center

Prescription Drug Prices: A Bitter Pill In The Midterm Elections

Nov 01, 2018 , Forbes
Older voters want Washington to do more about lowering prescription drug costs. The midterm elections may make that...
Read more

Trump's Proposed Medicare Drug Pricing Experiment Stokes Fears Of Price Controls

Nov 01, 2018 , Forbes
Trump's proposed Medicare drug pricing experiment raises questions concerning the appropriateness of the method used to calculate the international price index, and the fact that U.S. prices would piggyback on price controls set in non-U.S....
Read more

Pharma's support of Trump's drug pricing plan is fraying heading into midterms

Oct 31, 2018 , CNBC Health
A Trump administration plan to tie the prices of certain drugs paid for by Medicare to an international average has been met with some resistance from pharmaceutical executives, including Pfizer CEO Ian Read, heading into the midterm...
Read more

Medicare Advantage's Popularity Shows Americans Won't Like Single-Payer

Oct 30, 2018 , Forbes
Medicare Advantage shows that private-sector competition works. Private insurers have an incentive to provide high-quality care at low prices -- and to continuously improve service to attract...
Read more

Trump's Proposed Medicare Drug Pricing Experiment Stokes Fears Of Price Controls

Oct 29, 2018 , Forbes
Trump's proposed Medicare drug pricing experiment raises questions concerning the appropriateness of the method used to calculate the international price index, and the fact that U.S. prices would piggyback on price controls set in non-U.S....
Read more

Trump administration courts investors in broad effort to combat rising health care costs

Oct 29, 2018 , CNBC Health
The Trump administration is battling rising health costs by going after higher...
Read more

Trump Announces Plan to Cut Drug Prices

Oct 28, 2018 , MedicineNet
Title: Trump Announces Plan to Cut Drug PricesCategory: Health NewsCreated: 10/26/2018 12:00:00 AMLast Editorial Review: 10/26/2018 12:00:00...
Read more

Viewpoints: Poor Information On Gun Violence Undermines Public Safety Research; Smart Steps Begin On Reducing Some Drug Prices

Oct 27, 2018 , Kaiser Health News
Editorial pages focus on these health topics and...
Read more

Commentary: Abuse of U.S. patent system drives high drug prices

Oct 27, 2018 , Modern Healthcare Breaking News
The abuse and misuse of the patent system by drugmakers needs to stop, and patients and consumer advocates deserve more say in the patent...
Read more